Browsing by Subject "olsalazine; Crohn's disease; colitis; ileocolitis"
Now showing items 1-1 of 1
-
Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study
(BMJ, 2001)BACKGROUND AND AIMS: The benefit of 5-aminosalicylic acid therapy for maintenance of remission in Crohn's disease is controversial. The primary aim of this study was to evaluate the prophylactic properties of olsalazine ...